Distreptaza ®

About Synthaverse

Synthaverse is a modern, dynamically developing Polish biotech that leverages its expertise and proprietary technologies to develop and deliver solutions shaping global health. The company has a diversified portfolio of commercial and development-stage products, primarily in immunotherapy, and supports its innovation through close cooperation with scientific centers. Its ambition is to push the boundaries of medicine while maintaining a strong focus on contract manufacturing and laboratory reagents. Led by CEO Mieczysław Starkowicz, the company combines decades of experience with a forward-looking approach to research and production.

Therapeutic Areas